Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Nazareth N. Rocha is active.

Publication


Featured researches published by Nazareth N. Rocha.


Respiratory Research | 2014

Effects of different mesenchymal stromal cell sources and delivery routes in experimental emphysema

Mariana A. Antunes; Soraia C. Abreu; Fernanda F. Cruz; Ana Clara Teixeira; Miquéias Lopes-Pacheco; Elga Bandeira; Priscilla C. Olsen; Bruno L. Diaz; Christina Takyia; Isalira Prg Freitas; Nazareth N. Rocha; Vera Luiza Capelozzi; Debora G. Xisto; Daniel J. Weiss; Marcelo M. Morales; Patricia R.M. Rocco

We sought to assess whether the effects of mesenchymal stromal cells (MSC) on lung inflammation and remodeling in experimental emphysema would differ according to MSC source and administration route. Emphysema was induced in C57BL/6 mice by intratracheal (IT) administration of porcine pancreatic elastase (0.1 UI) weekly for 1 month. After the last elastase instillation, saline or MSCs (1-105), isolated from either mouse bone marrow (BM), adipose tissue (AD) or lung tissue (L), were administered intravenously (IV) or IT. After 1 week, mice were euthanized. Regardless of administration route, MSCs from each source yielded: 1) decreased mean linear intercept, neutrophil infiltration, and cell apoptosis; 2) increased elastic fiber content; 3) reduced alveolar epithelial and endothelial cell damage; and 4) decreased keratinocyte-derived chemokine (KC, a mouse analog of interleukin-8) and transforming growth factor-β levels in lung tissue. In contrast with IV, IT MSC administration further reduced alveolar hyperinflation (BM-MSC) and collagen fiber content (BM-MSC and L-MSC). Intravenous administration of BM- and AD-MSCs reduced the number of M1 macrophages and pulmonary hypertension on echocardiography, while increasing vascular endothelial growth factor. Only BM-MSCs (IV > IT) increased the number of M2 macrophages. In conclusion, different MSC sources and administration routes variably reduced elastase-induced lung damage, but IV administration of BM-MSCs resulted in better cardiovascular function and change of the macrophage phenotype from M1 to M2.


Respiratory Physiology & Neurobiology | 2012

Protective effects of bone marrow mononuclear cell therapy on lung and heart in an elastase-induced emphysema model

Fernanda F. Cruz; Mariana A. Antunes; Soraia C. Abreu; Livia Fujisaki; Johnatas D. Silva; Debora G. Xisto; Tatiana Maron-Gutierrez; Debora S. Ornellas; Vanessa Karen de Sá; Nazareth N. Rocha; Vera Luiza Capelozzi; Marcelo M. Morales; Patricia R.M. Rocco

We hypothesized that bone marrow-derived mononuclear cell (BMDMC) therapy protects the lung and consequently the heart in experimental elastase-induced emphysema. Twenty-four female C57BL/6 mice were intratracheally instilled with saline (C group) or porcine pancreatic elastase (E group) once a week during 4 weeks. C and E groups were randomized into subgroups receiving saline (SAL) or male BMDMCs (2 × 10(6), CELL) intravenously 3h after the first saline or elastase instillation. Compared to E-SAL group, E-CELL mice showed, at 5 weeks: lower mean linear intercept, neutrophil infiltration, elastolysis, collagen fiber deposition in alveolar septa and pulmonary vessel wall, lung cell apoptosis, right ventricle wall thickness and area, higher endothelial growth factor and insulin-like growth factor mRNA expressions in lung tissue, and reduced platelet-derived growth factor, transforming growth factor-β, and caspase-3 expressions. In conclusion, BMDMC therapy was effective at modulating the inflammatory and remodeling processes in the present model of elastase-induced emphysema.


Critical Care | 2010

Hypervolemia induces and potentiates lung damage after recruitment maneuver in a model of sepsis-induced acute lung injury

Pedro L. Silva; Fernanda F. Cruz; Livia Fujisaki; Gisele Pinto de Oliveira; Cynthia S. Samary; Debora S. Ornellas; Tatiana Maron-Gutierrez; Nazareth N. Rocha; Regina Coeli dos Santos Goldenberg; Cristiane Snb Garcia; Marcelo M. Morales; Vera Luiza Capelozzi; Marcelo Gama de Abreu; Paolo Pelosi; Patricia R.M. Rocco

IntroductionRecruitment maneuvers (RMs) seem to be more effective in extrapulmonary acute lung injury (ALI), caused mainly by sepsis, than in pulmonary ALI. Nevertheless, the maintenance of adequate volemic status is particularly challenging in sepsis. Since the interaction between volemic status and RMs is not well established, we investigated the effects of RMs on lung and distal organs in the presence of hypovolemia, normovolemia, and hypervolemia in a model of extrapulmonary lung injury induced by sepsis.MethodsALI was induced by cecal ligation and puncture surgery in 66 Wistar rats. After 48 h, animals were anesthetized, mechanically ventilated and randomly assigned to 3 volemic status (n = 22/group): 1) hypovolemia induced by blood drainage at mean arterial pressure (MAP)≈70 mmHg; 2) normovolemia (MAP≈100 mmHg), and 3) hypervolemia with colloid administration to achieve a MAP≈130 mmHg. In each group, animals were further randomized to be recruited (CPAP = 40 cm H2O for 40 s) or not (NR) (n = 11/group), followed by 1 h of protective mechanical ventilation. Echocardiography, arterial blood gases, static lung elastance (Est,L), histology (light and electron microscopy), lung wet-to-dry (W/D) ratio, interleukin (IL)-6, IL-1β, caspase-3, type III procollagen (PCIII), intercellular adhesion molecule-1 (ICAM-1), and vascular cell adhesion molecule-1 (VCAM-1) mRNA expressions in lung tissue, as well as lung and distal organ epithelial cell apoptosis were analyzed.ResultsWe observed that: 1) hypervolemia increased lung W/D ratio with impairment of oxygenation and Est,L, and was associated with alveolar and endothelial cell damage and increased IL-6, VCAM-1, and ICAM-1 mRNA expressions; and 2) RM reduced alveolar collapse independent of volemic status. In hypervolemic animals, RM improved oxygenation above the levels observed with the use of positive-end expiratory pressure (PEEP), but increased lung injury and led to higher inflammatory and fibrogenetic responses.ConclusionsVolemic status should be taken into account during RMs, since in this sepsis-induced ALI model hypervolemia promoted and potentiated lung injury compared to hypo- and normovolemia.


Journal of Cardiopulmonary Rehabilitation and Prevention | 2009

Noninvasive ventilation with continuous positive airway pressure acutely improves 6-minute walk distance in chronic heart failure.

Sergio S. M. Chermont; Mônica Quintão; Evandro Tinoco Mesquita; Nazareth N. Rocha; Antonio Claudio Lucas da Nóbrega

BACKGROUND Noninvasive ventilation with continuous positive airway pressure (CPAP) has been used in patients with chronic heart failure (CHF), although its effect on exercise tolerance in these patients is unknown. The aim of this study was to determine the effects of CPAP on exercise tolerance in outpatients with CHF. METHODS Following a double-blind, randomized, crossover, and placebo-controlled protocol, 12 patients with CHF (8 male; 4 female; age 54 ± 12 years; body mass index 27.3 ± 1.8 kg/m2, New York Heart Association Class II, III) underwent CPAP via nasal mask for 30 minutes in a recumbent position. Mask pressure was 3 cm H2O for 10 minutes, followed by individual progression up to 4 to 6 cm H2O, whereas placebo was fixed 0 to 1 cm H2O. A 6-minute walk test was performed after placebo and CPAP. RESULTS Continuous positive airway pressure decreased the resting heart rate (pre: 80 ± 17 bpm; post: 71 ± 15 bpm; P = .001) and mean arterial pressure (pre: 103 ± 14 mm Hg; post: 97 ± 13 mm Hg; P = .008). During exercise test, CPAP increased the distance covered (CPAP: 538 ± 78 m; placebo: 479 ± 83 m; P < .001) and the peak heart rate (CPAP: 98 ± 17; placebo: 89 ± 12 bpm; P = .049) but did not change the peak mean arterial pressure (P = .161). CONCLUSION Noninvasive ventilation with CPAP increased exercise tolerance in patients with stable CHF. Future clinical trials should investigate whether this effect is associated with improved clinical outcome.


Journal of Applied Physiology | 2012

Regular and moderate exercise before experimental sepsis reduces the risk of lung and distal organ injury

Carla C. Araujo; Johnatas D. Silva; Cynthia S. Samary; Isabela H. Guimarães; Patricia S. Marques; Gisele Pinto de Oliveira; Luana G. Carmo; Regina Coeli dos Santos Goldenberg; Ilka Bakker-Abreu; Bruno L. Diaz; Nazareth N. Rocha; Vera Luiza Capelozzi; Paolo Pelosi; Patricia R.M. Rocco

Physical activity modulates inflammation and immune response in both normal and pathologic conditions. We investigated whether regular and moderate exercise before the induction of experimental sepsis reduces the risk of lung and distal organ injury and survival. One hundred twenty-four BALB/c mice were randomly assigned to two groups: sedentary (S) and trained (T). Animals in T group ran on a motorized treadmill, at moderate intensity, 5% grade, 30 min/day, 3 times a week for 8 wk. Cardiac adaptation to exercise was evaluated using echocardiography. Systolic volume and left ventricular mass were increased in T compared with S group. Both T and S groups were further randomized either to sepsis induced by cecal ligation and puncture surgery (CLP) or sham operation (control). After 24 h, lung mechanics and histology, the degree of cell apoptosis in lung, heart, kidney, liver, and small intestine villi, and interleukin (IL)-6, KC (IL-8 murine functional homolog), IL-1β, IL-10, and number of cells in bronchoalveolar lavage (BALF) and peritoneal lavage (PLF) fluids as well as plasma were measured. In CLP, T compared with S groups showed: 1) improvement in survival; 2) reduced lung static elastance, alveolar collapse, collagen and elastic fiber content, number of neutrophils in BALF, PLF, and plasma, as well as lung and distal organ cell apoptosis; and 3) increased IL-10 in BALF and plasma, with reduced IL-6, KC, and IL-1β in PLF. In conclusion, regular and moderate exercise before the induction of sepsis reduced the risk of lung and distal organ damage, thus increasing survival.


American Journal of Pathology | 2012

Role of SOCS2 in Modulating Heart Damage and Function in a Murine Model of Acute Chagas Disease

Lisia Esper; Danilo Roman-Campos; Aline Lara; Fátima Brant; Luísa Lima Castro; Andréia Barroso; Ronan Ricardo S. Araujo; Leda Quercia Vieira; Shankar Mukherjee; Enéas R.M. Gomes; Nazareth N. Rocha; Isalira P.R. Ramos; Michael P. Lisanti; Camila França Campos; Rosa Maria Esteves Arantes; Silvia Guatimosim; Louis M. Weiss; Jader Santos Cruz; Herbert B. Tanowitz; Mauro M. Teixeira; Fabiana S. Machado

Infection with Trypanosoma cruzi induces inflammation, which limits parasite proliferation but may result in chagasic heart disease. Suppressor of cytokine signaling 2 (SOCS2) is a regulator of immune responses and may therefore participate in the pathogenesis of T. cruzi infection. SOCS2 is expressed during T. cruzi infection, and its expression is partially reduced in infected 5-lipoxygenase-deficient [knockout (KO)] mice. In SOCS2 KO mice, there was a reduction in both parasitemia and the expression of interferon-γ (IFN-γ), tumor necrosis factor-α (TNF-α), IL-6, IL-10, SOCS1, and SOCS3 in the spleen. Expression of IFN-γ, TNF-α, SOCS1, and SOCS3 was also reduced in the hearts of infected SOCS2 KO mice. There was an increase in the generation and expansion of T regulatory (Treg) cells and a decrease in the number of memory cells in T. cruzi-infected SOCS2 KO mice. Levels of lipoxinA(4) (LXA(4)) increased in these mice. Echocardiography studies demonstrated an impairment of cardiac function in T. cruzi-infected SOCS2 KO mice. There were also changes in calcium handling and in action potential waveforms, and reduced outward potassium currents in isolated cardiac myocytes. Our data suggest that reductions of inflammation and parasitemia in infected SOCS2-deficient mice may be secondary to the increases in Treg cells and LXA(4) levels. This occurs at the cost of greater infection-associated heart dysfunction, highlighting the relevance of balanced inflammatory and immune responses in preventing severe T. cruzi-induced disease.


Parasitology | 2006

Characterization of cardiopulmonary function and cardiac muscarinic and adrenergic receptor density adaptation in C57BL/6 mice with chronic Trypanosoma cruzi infection

Nazareth N. Rocha; Simone Garcia; Luis Eduardo Díaz Giménez; Ciria C. Hernandez; J.F. Senra; Reynaldo José da Silva Lima; F. Cyrino; E. Bouskela; Milena Botelho Pereira Soares; R. Ribeiro Dos Santos; A.C. Campos de Carvalho

Circulating antibodies in chagasic patients interact with myocardial beta adrenergic and muscarinic cholinergic receptors, triggering intracellular signals that alter cardiac function along the course of the disease. However, until now, experimental data in models of chronically infected chagasic mice linking the effects on myocardial beta adrenergic and muscarinic receptors to cardiopulmonary dysfunction is lacking. Thus, we studied C57BL/6 mice 8 months after intraperitoneal injection of 100 trypomastigote forms of the Colombian strain of T. cruzi. Uninfected mice, matched in age, were used as controls. Histopathological analyses (inflammation and fibrosis) and radio-ligand binding assays for estimation of muscarinic and adrenergic receptor density were performed in myocardium tissue samples. When compared to controls, infected mice had electrical conduction disturbances, diastolic dysfunction, lower O2 consumption and anaerobic threshold. In addition, hearts of chronic chagasic mice had intense inflammation and fibrosis, and decreased beta adrenergic and increased muscarinic receptor densities than normal controls. Our data suggest that chronic T. cruzi infection causes alterations in cardiac receptor density and fibrosis deposition which can be associated with cardiac conduction abnormalities, diastolic dysfunction and lower exercise capacity, associating for the first time all these functional and histopathological alterations in chagasic mice.


Stem Cell Research & Therapy | 2014

Improvement of cardiac function by placenta-derived mesenchymal stem cells does not require permanent engraftment and is independent of the insulin signaling pathway.

Juliana do Amaral Passipieri; Tais Hanae Kasai-Brunswick; Grazielle Suhett; Andreza B Martins; Guilherme Visconde Brasil; Dilza Campos; Nazareth N. Rocha; Isalira Peroba Ramos; D.B. Mello; Deivid C. Rodrigues; Beatriz B Christie; Bernardo J Silva-Mendes; Alex Balduino; Renato M Sá; Laudelino M Lopes; Regina Coeli dos Santos Goldenberg; Antonio Carlos Campos de Carvalho; Adriana Bastos Carvalho

IntroductionThe objective of this work was to evaluate the efficacy of placenta-derived mesenchymal stem cell (MSC) therapy in a mouse model of myocardial infarction (MI). Since MSCs can be obtained from two different regions of the human term placenta (chorionic plate or villi), cells obtained from both these regions were compared so that the best candidate for cell therapy could be selected.MethodsFor the in vitro studies, chorionic plate MSCs (cp-MSCs) and chorionic villi MSCs (cv-MSCs) were extensively characterized for their genetic stability, clonogenic and differentiation potential, gene expression, and immunophenotype. For the in vivo studies, C57Bl/6 mice were submitted to MI and, after 21 days, received weekly intramyocardial injections of cp-MSCs for 3 weeks. Cells were also stably transduced with a viral construct expressing luciferase, under the control of the murine stem cell virus (MSCV) promoter, and were used in a bioluminescence assay. The expression of genes associated with the insulin signaling pathway was analyzed in the cardiac tissue from cp-MSCs and placebo groups.ResultsMorphology, differentiation, immunophenotype, and proliferation were quite similar between these cells. However, cp-MSCs had a greater clonogenic potential and higher expression of genes related to cell cycle progression and genome stability. Therefore, we considered that the chorionic plate was preferable to the chorionic villi for the isolation of MSCs. Sixty days after MI, cell-treated mice had a significant increase in ejection fraction and a reduction in end-systolic volume. This improvement was not caused by a reduction in infarct size. In addition, tracking of cp-MSCs transduced with luciferase revealed that cells remained in the heart for 4 days after the first injection but that the survival period was reduced after the second and third injections. Quantitative reverse transcription-polymerase chain reaction revealed similar expression of genes involved in the insulin signaling pathway when comparing cell-treated and placebo groups.ConclusionsImprovement of cardiac function by cp-MSCs did not require permanent engraftment and was not mediated by the insulin signaling pathway.


Arquivos Brasileiros De Cardiologia | 1998

EVOLUCAO INTRA-HOSPITALAR E SEGUIMENTO POS-ALTA DE PACIENTES IDOSOS ATENDIDOS COM INSUFICIENCIA CARDIACA CONGESTIVA NA UNIDADE DE EMERGENCIA

Humberto Villacorta; Nazareth N. Rocha; Rosana Cardoso; Sergio Gaspar; Eduardo Reis Maia; Therezil Bonates; Daniel Kopiler; Hans F. Dohmann; Evandro Tinoco Mesquita

PURPOSE: To evaluate the in-hospital (IH) outcome and the short-term follow-up of predominantly elderly patients presenting to an emergency room (ER) with congestive heart failure (CHF). METHODS: In an 11 month period, 57 patients presenting to the ER with CHF were included. Mean age was 69+15 years (27 to 94) and 39 (68,4%) were male. CHF diagnosis was based on the Boston criteria. We evaluated IH outcome and prognosis in a mean follow-up of 5,7+2,7 months (1 to 12). In addition, some mortality predictors and mechanisms of death according on the ACME system were identified. RESULTS: Eight patients (14%) died in the IH period. Modes of death were circulatory failure (CF) in 7, and peri-operative (PO) in one (aortic valve replacement). During follow-up 9 deaths ocurred. Five were due to CF, 2 were sudden and 2 were PO (mitral valve replacement and ventriculectomy). Six-months and 1-year survival rates of the patients who were discharged were 82% and 66%, respectively. Sodium lower than 135mEq/l (p= 0.004) and female gender (p= 0.038) were independent predictors of mortality. CONCLUSION: Elderly patients with CHF admitted to the ER have high in-hospital and short-term follow up mortalities. The majority die from CF due to worsening heart failure.OBJETIVO: Conhecer a evolucao intra-hospitalar (IH) e pos-alta (PA) de uma populacao predominantemente idosa, com insuficiencia cardiaca congestiva (ICC) na unidade de emergencia (UE). METODOS: Durante 11 meses, foram selecionados 57 pacientes consecutivos com ICC, atendidos em EU, com idade media de 69+15 (27 a 94) anos, sendo 39 (68,4%) homens. O diagnostico de ICC baseou-se nos criterios de Boston. Avaliou-se a evolucao IH e PA num periodo medio de 5,7+2,7 (1 a 12) meses, procurando-se identificar variaveis que se correlacionassem com a mortalidade e o mecanismo de morte, avaliado pelo sistema ACME . RESULTADOS: Oito (14%) pacientes faleceram na fase IH, sendo 7 por falencia circulatoria (FC), e 1 em pos-operatorio (PO). Durante o seguimento ocorreram 9 (18,4%) obitos, sendo 5 por FC, 2 mortes subitas e 2 em PO (troca valvar mitral e ventriculectomia). A sobrevida dos pacientes que tiveram alta foi de 82% e 66%, aos 6 meses e 1 ano, respectivamente. Sodio serico <135mEq/l (p= 0,004) e sexo feminino (p= 0,038) foram preditores independentes de mortalidade. CONCLUSAO: Pacientes idosos com ICC atendidos em UE apresentam mortalidade IH e PA elevadas e alta taxa de reinternacao hospitalar. A maioria morre por falencia circulatoria decorrente da progressao da ICC.


Cell Transplantation | 2012

Adipose-derived stromal cell therapy improves cardiac function after coronary occlusion in rats.

Luiza de Lima e Silva Bagno; João Pedro Saar Werneck-de-Castro; Patrícia F. Oliveira; Márcia S. Cunha-Abreu; Nazareth N. Rocha; Tais Hanae Kasai-Brunswick; Vivian M. Lago; Regina Coeli dos Santos Goldenberg; Antônio Carlos Campos-de-Carvalho

Recent studies have identified adipose tissue as a new source of mesenchymal stem cells for therapy. The purpose of this study was to investigate the therapy with adipose-derived stromal cells (ASCs) in a rat model of healed myocardial infarction (MI). ASCs from inguinal subcutaneous adipose tissue of male Wistar rats were isolated by enzymatic digestion and filtration. Cells were then cultured until passage 3. Four weeks after ligation of the left coronary artery of female rats, a suspension of either 100 μl with phosphate-buffered saline (PBS) + Matrigel + 2 × 106 ASCs labeled with Hoechst (n = 11) or 100 μl of PBS + Matrigel (n = 10) was injected along the borders of the ventricular wall scar tissue. A sham-operated group (n = 5) was submitted to the same surgical procedure except permanent ligation of left coronary artery. Cardiac performance was assessed by electro- and echocardiogram. Echo was performed prior to injections (baseline, BL) and 6 weeks after injections (follow-up, FU), and values after treatment were normalized by values obtained before treatment. Hemodynamic measurements were performed 6 weeks after injections. All infarcted animals exhibited cardiac function impairment. Ejection fraction (EF), shortening fractional area (SFA), and left ventricular akinesia (LVA) were similar between infarcted groups before treatment. Six weeks after therapy, ASC group showed significant improvement in all three ECHO indices in comparison to vehicle group. In anesthetized animals dp/dt+ was also significantly higher in ASCs when compared to vehicle. In agreement with functional improvement, scar area was diminished in the ASC group. We conclude that ASCs improve cardiac function in infarcted rats when administered directly to the myocardium.

Collaboration


Dive into the Nazareth N. Rocha's collaboration.

Top Co-Authors

Avatar

Patricia R.M. Rocco

Federal University of Rio de Janeiro

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Cynthia S. Samary

Federal University of Rio de Janeiro

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Pedro L. Silva

Federal University of Rio de Janeiro

View shared research outputs
Top Co-Authors

Avatar

Paolo Pelosi

Ospedale di Circolo e Fondazione Macchi

View shared research outputs
Top Co-Authors

Avatar

Fernanda F. Cruz

Federal University of Rio de Janeiro

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Gisele A. Padilha

Federal University of Rio de Janeiro

View shared research outputs
Researchain Logo
Decentralizing Knowledge